BRCA1 and cancer: As a result, the NCCN (National Comprehensive Cancer Network) guidelines [7] suggest risk-reducing strategies for unaffected BRCA1/2 mutation carriers, including cancer surveillance, chemoprevention, and risk-reducing surgery.